Myeloid leukemia factor 1 Antibody (OTI3F11) [PerCP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-72849PCP
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot
Label
PerCP (Excitation = 490 nm, Emission = 675 nm)
Antibody Source
Monoclonal Mouse IgG2B Clone # OTI3F11
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Full length human recombinant protein of human MLF1(NP_071888) produced in E.coli.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for Myeloid leukemia factor 1 Antibody (OTI3F11) [PerCP]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Myeloid leukemia factor 1
Alternate Names
Myelodysplasia-myeloid leukemia factor 1, myeloid leukemia factor 1
Gene Symbol
MLF1
Additional Myeloid leukemia factor 1 Products
Product Documents for Myeloid leukemia factor 1 Antibody (OTI3F11) [PerCP]
Product Specific Notices for Myeloid leukemia factor 1 Antibody (OTI3F11) [PerCP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...